medigraphic.com
ISSN 2992-8559 (Electronic)
ISSN 1405-0625 (Print)

2007, Number 1

<< Back Next >>

Cir Plast 2007; 17 (1)

Facial tissue transplant:
composite tissue transplant antecedents; historical, immunological and pharmacological antecedents, rejection and functional recovery

Priego BR, Haddad TJL, Baltazar RB, Carmona BE, Caracheo R

Language: Spanish
References: 198
Page: 9-30
PDF size: 182.63 Kb.


ABSTRACT

In recent years medical advances have made the transplant of composite tissues, such as the hand transplant or the facial allograft possible, due to a combination of microsurgical techniques and better immunosuppressive drugs, resulting in a longer survival of allografts. One of the main issues that justify the use of facial allograft is that there is virtually an unlimited availability of tissue resembling the one lost by the patient. Another aspect and practically the most important in this kind of reconstruction gives the patient a complete functional reconstruction without the sequel left by skin grafts, flaps or the use of both. This is a review that focuses on the aspects in the evolution of composite tissue transplants and its application to facial allograft.


REFERENCES

  1. Hettiarachi S, Butler PE. Face transplantation: Fantasy or the future? Lancet 2002; 360: 5.

  2. Kmietowicz 2003

  3. Hettiarachi S, Butler PE. Extending the boundaries of transplantation. BMJ 2003; 326: 1226.

  4. Mackinnon SE, Doolabh VB, Novak CB, Trulock EP. Clinical outcome following nerve allograft transplantation. Plast Reconstr Surg 2001; 107: 1419.

  5. Lance EM, Inglis AE, Figarola F, Veith FJ, Veith FJ. Transplantation of the canine hind limb. J Bone Joint Surg 1971; 53A: 1137.

  6. Goldberg V, Porter BB, Lance EM. Transplantation of the canine knee joint on vascular pedicles. J Bone Joint Surg 1973; 55A: 1314

  7. Goldberg V, Porter BB, Lance EM. Transplantation of the canine knee joint on vascular pedicles. J Bone Joint Surg 1980; 62A: 414.

  8. Press B, Sibley RK, Shons AR. Limb allotransplantation in the rat: Extended survival and return of nerve function with continuous cyclosporin/prednisone immunosupression. Ann Plast Surg 1986; 16: 313.

  9. Siliski JM, Simpkin S, Green CJ. Vascularized whole knee joint allografts in rabbit’s immunosuppressed with cyclosporin A. Arch Orthop Trauma Surg 1984; 103: 26.

  10. Daniel RK, Egerszegi EP, Samulack DD, Skanes SE, Dykes RW, Rennie WR. Tissue transplants in primates for upper extremity reconstruction: a preliminary report. J Hand Surg (Am) 1986; 11: 1.

  11. Steinmuller D. The enigma of skin allograft rejection. Transplant Rev 1998; 12: 42.

  12. Gold ME, Randzio J, Kniha H et al. Transplantation of vascularized composite mandibular allografts in young cynomolgous monkeys. Ann Plast Surg 1991; 26: 125.

  13. Dubernard J-M, Owen E, Herzberg G et al. Human hand allograft. Report on first 6 months. Lancet 1999; 353: 1286.

  14. Dubernard JM, Owen ER, Lanzetta JM, Hakim N. What is happening with hand transplants? Lancet 2001; 357: 1711.

  15. Morris PJ, Bradley JA, Doyal L et al. Facial transplantation. Working Party Report. London. Royal College of Surgeons; 2003. http://www.rcseng.ac.uk.

  16. Canto-Sperber M. Deschamps C, Dien JM, Pellerin D, Lantieri L, Favre JD, Matzneff A, Bellavoir A. Composite tissue allotransplantation (CTA) of the face (full or partial facial transplant).

  17. Morris P, Bradley A, Doyal L, Earley M, Milling M, Rumsey N. Facial Transplantation. Working Party Report. 2 nd Edition, 2006. Disponible en: http://www.rcseng.ac.uk/rcseng/content/publications/docs/facial-transplantation. htlm

  18. Jensen JJ, Mackinnon S. Compositr Tissue allotransplantation: a comprehensive review of the literature- part I. J Reconstr Microsurgery 2000; 16(1): 57-68.

  19. Hewitt CW, Puglisi RN, Black KS. Current state of composite tissue and limb allotransplantation: Do present data justify clinical application? Transplant Proc 1995; 27: 1414.

  20. Llull R, Beko KR, Black KS, Hewitt CW. Composite tissue allotransplantation: Perspectives concerning eventual clinical exploitation. Transplant Rev 1992; 6: 175.

  21. Randolph MA, Yaremchuk MJ, Moore JR, et al. Experimental vascularized bone allografting. Microsurgery 1987; 8: 210.

  22. Porter BB, Lance EM. Limb and joint transplantation, a review of research and clinical experience. Clin Orthop 1974; 104: 249.

  23. Anthony JP, Allen DB, Trabulsy PP et al. Canyne laryngeal transplantation: Preliminary studies and a new heterotopic allotransplantation model. Eur Arch Otorhinolaryngol 1995; 252: 197.

  24. Schwind JV. Successful transplantation of a leg in albino rats with reestablishment of muscular control. Science 1936; 84: 355.

  25. Schwind JV. Leg transplantation in rats. J Exp Zool 1938; 77: 337.

  26. Schwind JV. Homotransplantation by parabiosis. J Surg Res 1962; 2: 332.

  27. Goldwyn RM, Beach PM, Feldman D, Wilson RE. Canine limb homotransplantations. Plast Reconstr Surg 1966; 37:184.

  28. Reeves B. Studies of vascularized homotransplants of the knee joint. J Bone Joint Surg 1968; 50B: 232.

  29. Reeves B. Orthotopic transplantation of vascularized whole knee-joints in dogs. Lancet 1969; 1(7593): 500.

  30. Lance EM, Leavey RH, Medawar PB, Ruszkiewicz M. Tolerance of rat skin grafts in adult mice. Proc Nat Acad Sci 1979; 64: 1356.

  31. Lapchinsky AG, Eingorn AG, Uratkov EF. Homotransplantation of extremities in tolerant dogs observed up to seven years. Transplant Proc 1973; V: 773.

  32. Lapchinsky AG, Medvedeva GV, Gadalina ID et al. Homotransplantation of skin and mammary glands in rats by parabiosis of the donor and host in rats. Ann NY Acad Sci 1964; 120: 435.

  33. Poole M, Bowen JE, Batchelor JR. Prolonged survival of rat leg allografts due to immunological enhancement. Transplantation 1976; 22: 108.

  34. Black KS, Hewit CW, Fraser LA et al. Cosmas and Damian in the laboratory. N Engl J Med 1982; 306: 368.

  35. Shapiro RI, Cerra FB. A model for reimplantation and transplantation of a complex organ: The rat limb. J Surg Res 1978; 24: 501.

  36. Palm J, Black G. Interrelationships of inbread rats strains with respect to Ag-B antigens. Transplantation 1971; 11: 184.

  37. Gill TJ. Report of the first international workshop on alloantigenic systems in the rat. Transplant Proc 1978; X: 271.

  38. Borel JF, Feurer C, Gubler HU, Stahelin H. Biological effects of cyclosporin A: A new antilymphocytic agent. Agents Actions 1976; 6: 613.

  39. Borel JF Feurer C, Magnee C, Stahelin H. Effects of the new anti-lymphocytic peptide cyclosporin A in animals. Immunology 1977; 32: 1017.

  40. Calne R, White DJ, Rolles K et al. Prolonged survival of pig orthotopic heart grafts treated with cyclosporin A. Lancet 1978; 1(8115): 545.

  41. Jamieson SW, Burton NA, Bieber CP et al. Survival of cardiac allografts in rats treated with cyclosporin A. Aur Forum 1979; 30: 289.

  42. Green CJ, Allison AC. Extensive prolongation of rabbit kidney allograft survival after short-term cyclosporin-A treatment. Lancet 1979; 1(8075): 1182.

  43. Cosimi AB, Shield CF, Peters C et al. Prolongation of allograft survival by cyclosporin A. Sur Forum 1979; 30: 287.

  44. Homan WP, Fabre JW, Williams KA et al. Studies on the immunosuppressive properties of cyclosporin A in rats receiving renal allografts. Transplantation 1980; 29: 361.

  45. Homan WP, French ME, Millard P et al. Studies on the effects of cyclosporin A upon renal allograft rejection in the dog. Surgery 1980; 88: 168.

  46. Calne RY, White DJ, Pentlow BD et al. Cyclosporin A: Preliminary observations in dogs with pancreatic duodenal allografts and patients with cadaveric renal transplants. Transplant Proc 1979; 11: 860.

  47. Garvey Jf, McShane P, Poole MD et al. The effect of cyclosporin A on experimental pancreas allografts in the rat. Transplant Proc 1980; 12: 266.

  48. Rynasiewicz JJ, Sutherland DE, Kawahara K et al. Cyclosporin A prolongation of segmental pancreatic and islet allograft function in rats. Transplant Proc 1980; 12: 270.

  49. Norin AJ, Veith FJ, Emeson EE et al. Improved survival of transplanted lungs in mongrel dogs treated with cyclosporin A. Transplantation 1981; 32: 259.

  50. Reitz BA, Burton NA, Jamieson SW et al. Heart and lung transplantation: Autotransplantation and allotransplantation in primates with extended survival. J Thorac Cardiovasc Surg 1980; 80: 360.

  51. Reznick RK, Craddock GN, Langer B et al. Structure and function of small bowel allografts in the dog: Immunosupression with cyclosporin A. Can J Sur 1982; 25: 51.

  52. Shepherd WF, Coster DJ, Fook TC et al. Effect of cyclosporin A on the survival of corneal grafts in rabbits. Br J Ophthalmol 1980; 64: 148.

  53. Borel JF, Meszaros J. Skin transplantation in mice and dogs. Effect of cyclosporin A and dihydrocyclosporin C. Transplantation 1980; 29: 161.

  54. Zalaweski AA, Gulati AK. Survival of nerve and Schwann cells in allografts after cyclosporin A treatment. Exp Neurol 1980; 70: 219.

  55. Watt DJ, Patridge TA, Sloper JC. Cyclosporin A as a means of preventing rejection of skeletal muscle allografts in mice. Transplantation 1981; 31: 266.

  56. Black KS, Hewitt CW, Woodard TL et al. Efforts to enhance survival of limb allografts by prior administration of whole blood in rats using a new survival end-point. J Microsurg 1982; 3: 162.

  57. Lipson RA, Kawano H, Halloran PF et al. Vascularized limb transplantation in the rat I: Results with synergic grafts. Transplantation 1983; 35: 293.

  58. Lipson RA, Kawano H, Halloran PF et al. Vascularized limb transplantation in the rat II: Results with allogenetic grafts. Transplantation 1983; 35: 300.

  59. Halloran PF, Bushuk M, Stewart JA. Effects of cyclosporin on the healing of vascularized and non vascularized bone allografts in rodents. Transplant Proc 1983; XV (Suppl 1): 3053.

  60. Fritz WD, Swartz WM, Rose S et al. Limb allografts in rats immunosuppressed with cyclosporin A. Ann Surg 1984; 199: 211.

  61. Kuroki H, Ikuta Y, Akiyama M. Experimental studies of vascularized allogeneic limb transplantation in the rat using a new immunosuppressive agent, FK 506: Morphological and immunological analysis. Transplant Proc 1989; 21: 3187.

  62. Harashina T Bunke HJ. Study of washout solutions for microvascular replantation and transplantation. Plast Reconstr Surg 1975; 56: 542.

  63. Kniha H, Randzio J, Gold ME et al. Growth of forelimb allografts in young rabbits immunosupressed with cyclosporine. Ann Plast Surg 1989; 22: 135.

  64. Randzio J, Khina H, Gold ME et al. Growth of vascularized composite mandibular allografts in young rabbits. Ann Plast Surg 1991; 26: 140.

  65. Black KS, Hewitt CW, Grisham GR et al. Two new composite tissue allograft models in rats to study neuromuscular functional return. Transplant Proc 1987; XIX: 1118.

  66. Yeh LS, Hou SM, Lin AC, Lin J. A modified free gracilis flap in the rat. Microsurgery 1994; 15: 322.

  67. Yeh LS, Gregory CR, Griffey SM et al. Effects of leflunomide and cyclosporin on myocutaneous allograft survival in the rat. Transplantation 1996; 62: 861.

  68. Butler PEM, Lee WPA, Sims CD et al. Cell transplantation from limb allografts. Plast Reconstr Surg 1998; 102: 161.

  69. Lee WPA, Rubin JP, Cober S et al. Use of swine model in transplantation of vascularized skeletal tissue allografts. Transplant Proc 1998; 30: 2743.

  70. Üstüner ER, Zdichavsky M, Ren X et al. Long-term composite tissue allograft survival in porcine model with cyclosporin/mycophenolate mofetil therapy. Transplantation 1998; 66: 1581.

  71. Press BHJ, Sibley RK, Shons AR. Modification of experimental limb allograft rejection with cyclosporin and prednisone: A preliminary report. Transplant Proc 1983; XV (Suppl 1): 3057.

  72. Inceoglu S, Siemionow M, Chick L et al. The effect of combined immunosuppression with systemic low-dose cyclosporin and topical fluocinolone acetonide on the survival of rat hind-limb allografts. Ann Plast Surg 1994; 33: 57.

  73. Rosso R, Schaefer D, Fricker R et al. Functional and morphological outcome of knee joint transplantation in dogs depends on control of rejection. Transplantation 1997; 63: 1723.

  74. Yaremchuk MJ, Sedacca T, Schiller AL, May JW. Vascular knee allograft transplantation in a rabbit model. Plast Reconstr Surg 1983; 71: 461.

  75. Swartz WM, Cha CM, Clowes GHA, Randall HT. The effect of prolonged ischemia on high energy phosphate metabolism in skeletal muscle. Surg Gynecol Obstet 1978; 147: 872.

  76. Eckert P, Schnackerz K. Ischemic tolerance of human skeletal muscle. Ann Plast Surg 1991; 26: 77.

  77. Hicks TE, Boswick JA, Solomons CC. The effects of perfusion on an amputated extremity. J Trauma 1980; 20: 632.

  78. Kihira M, Miura T, Ishiguro N. Preservation of skeletal muscle in tissue transfers using rat hindlimbs. Plast Reconstr Surg 1991; 88: 275.

  79. Arai K, Hotokebuchi T, Miyahara H et al. Successful long-term storage of rats limbs: The use of simple immersion in Euro-Collins solution. Int Orthoped 1993; 17: 389.

  80. Norden MA, Rao VK, Southard JH. Improved preservation of rats hindlimbs with the University of Wisconsin solution and butanedione monoxime. Plast Reconstr Surg 1997; 100: 957.

  81. Black KS, Hewit CW, Fraser LA et al. Composite tissue (limb) allografts in rats II: Indefinite survival using low-dose cyclosporin. Transplantation 1985; 39: 365.

  82. Hewitt CW, Black KS, Fraser LA et al. Composite tissue (limb) allografts in rats I: Dose-dependent increase in survival with cyclosporin. Transplantation 1985; 39: 360.

  83. Min Z, Jones NF. Limb transplantation in rats: Immunosuppression with FK-506. J Hand Surg 1995; 20A: 77.

  84. Furnas DW, Black KS, Hewitt CW et al. Cyclosporine and long-term survival of composite tissue allografts (limb transplants) in rats (with historical notes on the role of plastic surgeons in allotransplantation). Transplant Proc 1983; XV (Suppl 1): 3063.

  85. Black KS, Hewitt CW, Hwang JS et al. Dose response of cyclosporin-treated composite tissue allografts in a strong histocompatible rat model. Transplant Proc 1988; XX: 266.

  86. Kim SK, Aziz S, Oyer P, Hentz VR. Use of cyclosporin A in allotransplantation of rat limbs. Ann Plast Surg 1984; 12: 249.

  87. Fealy MJ, Umansky WS, Bickel KD et al. Efficacy of rapamycin and FK506 in prolonging rat hind limb allograft survival. Ann Surg 1994; 219: 88.

  88. Buttemeyer R, Jones NF, Min Z, Rao U. Rejection of the component tissues of limb allografts in rats immunosuppressed with FK-506 and cyclosporin. Plast Reconstr Surg 1995; 97: 139.

  89. Muramatsu K, Doi K, Akino T et al. Longer survival of rat limb allograft: Combined immunosuppression of FK-506 and 15-deoxyspergualin. Acta Orthop Scan 1997; 68: 581.

  90. Muramatsu K, Doi K, Shigetomi M et al. A new immunosuppressant, FTY720, prolongs limb allograft survival in rats. Ann Plast Surg 1998; 40: 160.

  91. Arai K, Hotokebuchi T, Miyahara H et al. Limb allografts in rats immunosuppressed with FK506 I: Reversal of rejection and indefinite survival. Transplantation 1989; 48: 782.

  92. Hotokebuchi T, Arai K, Arita C et al. Limb allografts in skeletally immature rats with cyclosporin: Behavior of the growth plate. Transplant Proc 1989; 21: 3183.

  93. Hebebrand D, Jones NF, Zohman G et al. Limb xenotransplantation using FK506 and RS61443 immunosuppression. J Reconstr Microsurg 1998; 14: 191.

  94. Walter P, Menger MD, Thies J et al. Prolongation of grafts survival in allogeneic limb transplantation by 15-deoxyspergualin. Trans Proc 1989; 21: 3186.

  95. Kuroki H, Bean MA, Ikuta Y et al. Effect of FK-506 and donor-specific blood transfusion on the rat composite tissue limb allograft and the mechanism of long-term graft survival. Transplant Proc 1993; 25: 658.

  96. Kuroki H, Bean MA, Ikuta Y, Burgess EM. Synergistic effect of FK-506 and donor-specific blood transfusion on rat skin but not on composite tissue (limb) allograft survival. Transplant Proc 1991; 23: 3282.

  97. Uesteuner ET, Zdichavsky M, Ren X et al. Long-term composite tissue allograft survival in porcine model with cyclosporin/micophenolate mofetil therapy. Transplantation 1998; 66: 1581.

  98. Black KS, Hewit CW, Howard EB et al. Diagnosis of rejection and functional analysis of composite tissue (CT) and skin allografts prolonged with cyclosporin. Transplant Proc 1983; XV (4 Suppl 1): 3069.

  99. Hovius SER, van Adrichem LNA, van der Hiejden PMA et al. Postoperative monitoring of allogeneic limb transplantation in rats. Ann Plast Surg 1988; 21: 559.

  100. Benhaim P, Anthony JP, Lin T et al. A long-term study of allogenetic rat hindlimb transplants immunosuppressed with RS-61443. Transplantation 1993; 56: 911.

  101. van den Helder TBM, Benhaim P, Anthony JP et al. Efficacy of RS-61443 in reversing acute rejection in a rat model of hindlimb allotransplantation. Transplantation 1994; 57: 427.

  102. Fritz WD, Swartz WM, Rose S et al. Limb allografts in rats immunosuppressed with cyclosporin A. Ann Surg 1984; 199: 211.

  103. Hotokebuchi T, Arai K, Arita C et al. Limb allografts in skeletally immature rats with cyclosporin: Behavior of the growth plate. Transplant Proc 1989; 21: 3183.

  104. Muramatsu K, Doi K, Shigetomi M et al. A new immunosuppressant, FTY720, prolongs limb allograft survival in rats. Ann Plast Surg 1998; 40: 160.

  105. Hebebrand D, Jones NF, Zohman G et al. Limb xenotransplantation using FK506 and RS61443 immunosuppression. J Reconstr Microsurg 1998; 14: 191.

  106. Paskert JP, Yaremchuk MJ, Randolph MA, Weiland AJ. The role of cyclosporin in prolonging survival in vascularized bone allografts. Plast Reconstr Surg 1987; 80: 240.

  107. Lee WPA, Pan Y-C, Kesmarsky S et al. Experimental orthotopic transplantation of vascularized skeletal allografts: Functional assessment and long-term survival. Plast Reconstr Surg 1995; 95: 336.

  108. Kuroki H, Ikuta Y, Akiyama M. Experimental studies of vascularized allogeneic limb transplantation in the rat using a new immunosuppressive agent, FK 506: Morphological and immunological analysis. Transplant Proc 1989; 21: 3187.

  109. Press B, Sibley RK, Shons AR. Limb allotransplantation in the rat: Extended survival and return of nerve function with continuous cyclosporine/prednisone immunosupression. Ann Plast Surg 1986; 16: 313.

  110. Gudemez E, Turegun M, Zins J, Siemionow M. Microvascular permeability following composite tissue transplantation. Ann Plast Surg 1998; 41: 519.

  111. Hotokebuchi T, Arai K, Takagishi K et al. Limb allografts in rats immunosuppressed with cyclosporine: As a whole-joint allograft. Plast Reconstr Surg 1989; 83: 1027.

  112. Gottfried Y, Yaremchuk MJ, Randolph MA, Weiland AJ. Immunologic and ultrastructural changes during early rejection of vascularized bone allografts. Plast Reconstr Surg 1991; 88: 860.

  113. Gornet MF, Randolph MA, Schofield BH, et al. Immunologic and ultrastructural changes during early rejection of vascularized bone allografts. Plast Reconstr Surg 1991; 88: 860.

  114. Innis PC, Randolph MA, Paskert JP, et al. Vascularized bone allografts: In vitro assessment of cell-mediated and humoral responses. Plast Reconstr Surg 1991; 87: 315.

  115. Kuroki H, Ikuta Y. Nerve regeneration of vascularized rat limb allograft and functional recovery of long-term graft survival treated by short course of FK-506 or cyclosporine. Transplant Proc 1995; 27: 348.

  116. Stepkowski SM, Kahan BD. Rapamycin and cyclosporin synergistically prolong heart and kidney allograft survival. Transplant Proc 1991; 23: 3262.

  117. Stepkowski MS, Chen H, Daloze P, Kahan BD. Rapamycin a potent immunosuppressive drug for vascularized heart, kidney, and small bowel transplantation in the rat. Transplantation1991; 51: 22.

  118. Hewitt CW, Black KS, Fraser LA et al. Cyclosporine-A (CyA) is superior to prior donor-specific blood (DSB) transfusion for the extensive prolongation of rat limb allograft survival. Transplant Proc 1983; XV: 514.

  119. Hewitt CW, Black KS, Gonzalez GA et al. Long-term residual cyclosporine levels following short-term administration in various allograft models demonstrating extensive survival prolongation. Transplant Proc 1987; XIX: 1244.

  120. Platz KP, Eckhoff DE, Hullet DA, Sollinger HW. Prolongation of dog renal allograft survival by RS=61443, a new potent immunosuppressive agent. Transplant Proc 1991; 23 (1 Pt 1): 497.

  121. Platz KP, Sollinger HW, Hullett DA et al. RS-61443- a new potent immunosuppressive agent. Transplantation 1991; 51: 27.

  122. Norden MA, Rao VK, Southard JH. Improved preservation of rats hindlimbs with the University of Wisconsin solution and butanedione monoxime. Plast Reconstr Surg 1997; 100: 957.

  123. Norin AJ, Veith FJ, Emeson EE et al. Improved survival of transplanted lungs in mongrel dogs treated with cyclosporin A. Transplantation 1981; 32: 259.

  124. Hewitt CW, Black KS, Fraser LA et al. Composite tissue (limb) allografts in rats I: Dose-dependent increase in survival with cyclosporin. Transplantation 1985; 39: 360.

  125. Llull R, Beko KR, Black KS, Hewitt CW. Composite tissue allotransplantation: Perspectives concerning eventual clinical exploitation. Transplant Rev 1992; 6: 175.

  126. Llull R, Marase N, Ye Q et al. Chimerism, graft–vs-host disease, rejection, and their association with reciprocal donor-host immune reactions after cell, organ, and composite tissue transplantation. Transplant Proc 1997; 29: 1203.

  127. Paskert JP, Yaremchuk MJ, Randolph MA, Weiland AJ. The role of cyclosporin in prolonging survival in vascularized bone allografts. Plast Recotr Surg 1987; 80: 240.

  128. Gottfried Y, Yaremchuk MJ, Randolph MA, Weiland AJ. Immunologic and ultrastructural changes during early rejection of vascularized bone allografts. Plast Reconstr Surg 1991; 88: 860.

  129. Gudemez E, Turegun M, Zins J, Siemionow M. Microvascular permeability following composite tissue transplantation. Ann Plast Surg 1998; 41: 519.

  130. Halloran PF, Bushuk M, Stewart JA. Effects of cyclosporin on the healing of vascularized and non vascularized bone allografts in rodents. Transplant Proc 1983; XV (Suppl 1): 3053.

  131. Walter P, Menger MD, Thies J et al. Prolongation of grafts survival in allogeneic limb transplantation by 15-deoxyspergualin. Trans Proc 1989; 21: 3186.

  132. Arai K, Hotokebuchi T, Miyahara H, et al. Prolonged limb allograft survival with short-term treatment with FK-506 in rats. Transplant Proc 1989; 21: 3191.

  133. Llull R, Marase N, Ye Q et al. Chimerism, graft–vs-host disease, rejection, and their association with reciprocal donor-host immune reactions after cell, organ, and composite tissue transplantation. Transplant Proc 1997; 29: 1203.

  134. Morris RE, Hoyt EG, Murphy MP et al. Mycophenolic acid morpholinoethylester (RS-61443) is a new immunosuppressant that prevents and halts allografts rejection by selective inhibition of T- and B-cell purine synthesis. Transplant Proc 1990; 22: 1659.

  135. Morris RE, Wang J. Comparison of the immunosuppressive effects of mycophenolic acid (RS-61443) in recipients of heart allografts. Transplant Proc 1991; 23 (1 Pt 1): 493.

  136. Hewitt CW, Puglish RN, Black KS. Current state of composite tissue and limb allotransplantation: Do present data justify clinical application? Transplant Proc 1992; 27: 1414.

  137. Hicks TE, Boswick JA, Solomons CC. The effects of perfusion on an amputated extremity. J Trauma 1980; 20: 632.

  138. Hewitt CW, Black KS, Fraser LA et al. Cyclosporin-A (CyA) is superior to prior donor-specific blood (DSB) transfusion for the extensive prolongation of rat limb allograft survival. Transplant Proc 1983; XV: 514.

  139. Hotokebuchi T, Arai K, Takagishi K et al. Limb allografts in rats immunosuppressed with cyclosporin: As a whole-joint allograft. Plast Reconstr Surg 1989; 83: 1027.

  140. Siliski JM, Simpkin S, Green CJ. Vascularized whole knee joint allografts in rabbits immunosuppressed with cyclosporin A. Arch Orthop Trauma Surg 1984; 103:26.

  141. Rosso R, Schaefer D, Fricker R et al. Functional and morphological outcome of knee joint transplantation in dogs depends on control of rejection. Transplantation 1997; 63: 1723.

  142. Doi K, DeSantis G, Singer DI et al. The effect of immunosuppression on vascularized allografts. J Bone Joint Surg 1989; 71B: 576.

  143. Morris PJ, Bradley JA, Doyal L, Earley M et al. Facial transplantation: A working party report from the royal college of surgeons of England. Transplantation 2004; 77(3): 330.

  144. Ochiai T, Nagata M, Nakajima K et al. Prolongation of canine renal allograft survival by treatment with FK-506. Transplant Proc 1987; 19 (5 Suppl 6): 53.

  145. Ochiai T, Nakajima K, Nagata M et al. Effect of a new immunosuppressive agent, FK-506, on heterotopic cardiac allotransplantation in the rat. Transplant Proc 1987; 19: 1284.

  146. Kino T, Inamura N, Sakai F et al. Effect of FK-506on human mixed lymphocyte reaction in vitro. Transplant Proc 1987; 19 (Suppl 6): 36.

  147. Ochiai T, Nakajima K, Nagata M et al. Effects of FK-506 on xenotransplantation of the heart and skin in a mouse-rat combination. Transplant Proc 1987; 19 (5 Suppl 6): 79.

  148. Kino T, Hatanaka H, Miyata S et al. FK-506, a novel immunosuppressant isolated from streptomices. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot 1987; 40: 1256.

  149. Goto T, Kino T, Hatanaka H et al. Discovery of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis. Transplant Proc 1987; 19 (5 Suppl 6): 4.

  150. Ochiai T, Nakajima K, Nagata M et al. Studies of induction and maintenance of long-term grafo acceptance by treatment with FK-506 in heterotopic cardiac allotransplantation in rats. Transplantation 1987; 44: 734.

  151. Collier DS, Calne R, Thiru S et al. FK-506in experimental renal allografts. Transplant Proc 1987; 19: 3975.

  152. Calne R, Collier DS, Thiru S. Observation about FK-506 in primates. Transplant Proc 1987; 19 (5 Suppl 6): 63.

  153. Lim AM, Thiru S, White DJ. Heterotopic heart transplantation in the rat receiving FK-506. Transplant Proc 1987; 19 (5 Suppl 6): 68.

  154. Collier DS, Thiru S, Calne R. Kidney transplantation in the dog receiving FK-506. Transplant Proc 1987; 19 (5 Suppl 6): 53.

  155. Makowka L, Chapman F, Quian S et al. The effect of FK-506 on hyperacute rejection in presensitized rats. Transplant Proc 1987; 19 (5 Suppl 6): 79.

  156. Murase N, Todo S, Lee PH et al. Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporin. Transplant Proc 1987; 19 (5 Suppl 6): 71.

  157. Sawada S, Susuki G, Kawase Y, Takatu F. Novel immunosuppressive agent, FK-506: In vitro effects on cloned T cell activation. J Immunol 1987; 139: 1797.

  158. Tanaka H, Kuroda A, Marusawa H, et al. Physicochemical properties of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis. Transplant Proc 1987; 19 (5 Suppl 6): 11.

  159. Todo S, Podesta L, Chap P et al. Orthotopic liver transplantation in dogs receiving FK-506. Transplant Proc 1987; 19 (5 Suppl 6): 64.

  160. Umeda Y, Moriguchi M, Kuroda H et al. Synthesis and antitumor activity of spergualin analogues. I. Chemical modification of 7-guanidino- 3- hydroxyacyl moiety. J Antibiot 1985; 38: 886.

  161. Iwasawa H, Kondo S, Ikeda D et al. Synthesis of (-)-15-de-oxyspergualin and (-)spergualin-15 – phosphate. J Antibiot 1982; 35: 1665.

  162. Hao L, Lafferty KJ, Allison AC, Eugui EM. RS-61443 allows islet allografting and specific tolerance induction in adult mice. Transplant Proc 1990; 22: 876.

  163. Morris RE, Hoyt EG, Murphy MP, et al. Mycophenolic acid morpholinoethylester (RS-61443) is a new immunosuppressant that prevents and halts allografts rejection by selective inhibition of T- and B-cell purine synthesis. Transplant Proc 1990; 22: 1659.

  164. Platz KP, Bechstein WO, Eckhoff DE et al. RS-61443 reverses acute allograft rejection in dogs. Surgery 1991; 110: 736.

  165. Platz KP, Eckhoff DE, Hullet DA, Sollinger HW. Prolongation of dog renal allograft survival by RS=61443, a new potent immunosuppressive agent. Transplant Proc 1991; 23 (1 Pt 1): 497.

  166. Shaffer D, Blakely ML, Gottschalk R, Monaco AP. Small bowel transplantation in rats using RS-61443: Effect on GVHD and rejection. Transplant Proc 1992; 24: 1159.

  167. Coulombe M, Hao L, Calcinaro F et al. Tolerance induction in adult animals: Comparison of RS-61443 and anti-CD4 treatment. Transplant Proc 1991; 23 (2 Suppl 2): 31.

  168. Platz KP, Bechstein WO, Eckhoff DE, et al. RS-61443 reverses acute allograft rejection in dogs. Surgery 1991; 110: 736.

  169. Sollinger HW, Deierhoi MH, Belzer FO et al. Rs-61443-A phase clinical trial and pilot rescue study. Transplantation 1992; 53: 428.

  170. Benhaim P, Anthony JP, Ferreira L et al. Use of combination of low-dose cyclosporin and RS-61443 in a rat model of composite tissue allotransplantation. Transplantation 1996; 61: 527.

  171. Vezina C, Kudelski A, Sehgal SN. Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomyce and isolation of the active principle. J Antibiot 1975; 28: 721.

  172. Calne R, Collier DS, Lim S et al. Rapamycin for immunosuppression in organ allografting (letter). Lancet 1989; 8656: 227.

  173. Stepkowski SM, Kahan BD. Rapamycin and cyclosporin synergistically prolong heart and kidney allograft survival. Transplant Proc 1991; 23: 3262.

  174. Fealy MJ, Most D, Huie P et al. Association of downregulation of cytokine activity with rat hind limb allograft survival. Transplantation 1995; 59: 1475.

  175. Fujita T, Inoue K, Yamamoto S et al. Fungal metabolites. Part II. A potent immunosuppressive activity found in Isaria sinclairii metabolite. J Antibiot 1994; 47: 208.

  176. Suzuki S, Enosawa S, Kakefuda T et al. A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog allotransplantation. Transplantation 1996; 61: 200.

  177. Suzuki S, Li XK, Enosawa S, Shinomiya T et al. Induction of lymphocyte apoptosis and prolongation of graft survival by FTY720. Transplant Proc 1996; 28: 2049.

  178. Suzuki S, Li XK, Enosawa S, Shinomiya T. A new immunosuppressant, FTY720, induces bel-2-associated apoptotic cell death in human lymphocytes. Immunology 1996; 89: 518.

  179. Aboujaqude M, Chen H, Wu J et al. Efficacy of rapamycin in limb transplantation in the rat. Clin Invest Med 1991; 14: A 146.

  180. Kahan BD, Gibbons S, Tejpal N et al. Synergistic interactions of cyclosporine and rapamicyn to inhibit immune performances of normal human peripheral blood lymphocytes in vitro. Transplantation 1991; 51: 232.

  181. Stepkowski MS, Chen H, Daloze P, Kahan BD. Rapamycin a potent immunosuppressive drug for vascularized heart, kidney, and small bowel transplantation in the rat. Transplantation 1991; 51: 22.

  182. Yeh LS, Gregory CR, Griffey SM et al. Effects of leflunomide and cyclosporin on myocutaneous allograft survival in the rat. Transplantation 1996; 62: 861.

  183. Yeh L-S, Gregory CR, Griffey SM et al. Combination leflunomide and cyclosporin prevents rejection of functional whole limb allografts in the rat. Transplantation 1997; 64: 919.

  184. Kuchle CCA, Thoenes GH, Langer KH et al. Prevention of kidney and skin graft rejection in rats by leflunomide, a new immunomodulating agent. Transplant Proc 1991; 23 (1 pt 2 ): 1083.

  185. Lirtzman RA, Gregory CR, Levitski RE, et al. Combined immunosuppression with leflunomide and cyclosporin prevents MLR-mismatched renal allograft rejection in a mongrel canine model. Transplant Proc 1996; 28: 945.

  186. Edelstein J, Tecimer T, Uestuener T et al. Effect of FK506 versus cyclosporin A-based combination therapy on muscle/tendon and bone rejection in a preclinical composite tissue allograft. Plastic Surgery Research Council 1999.

  187. MacKinnon SE, Doolabh VB, Novak CB, Trulock EP. Clinical outcome following nerve allograft transplantation. Plast Reconstr Surg 2001; 107: 1419.

  188. Kuroki H, Ikuta Y. Nerve regeneration of vascularized rat limb allograft and functional recovery of long-term graft survival treated by short course of FK-506 or cyclosporin. Transplant Proc 1995; 27: 348.

  189. Lee WPA, Pan Y-C, Kesmarsky S et al. Experimental orthotopic transplantation of vascularized skeletal allografts: Functional assessment and long-term survival. Plast Reconstr Surg 1995; 95: 336.

  190. Thiru S, Collier DS, Calne R. Pathological studies in canine and baboon renal allograft recipients immunosuppressed with FK-506. Transplant Proc 1897; 19 (5 Suppl 6): 98.

  191. Jensen JJ, MacKinnon S. Compositr Tissue allotransplantation: a comprehensive review of the literature- part II. J Reconstr Microsurgery 2000; 16(2): 141-157.

  192. Jensen JJ, MacKinnon S. Compositr Tissue allotransplantation: a comprehensive review of the literature- part III. J Reconstr Microsurgery 2000; 16(3): 235-251.

  193. Doerrler J, Goering H, Gossmann R et al. Limb allograft survival under cyclosporin treatment. Transplant Proc 1986; XVIII: 1431.

  194. Yeh L-S, Gregory CR, Griffey SM et al. Combination leflunomide and cyclosporin prevents rejection of functional whole limb allografts in the rat. Transplantation 1997; 64: 919.

  195. Tanaka H, Kuroda A, Marusawa H et al. Physicochemical properties of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis. Transplant Proc 1987; 19 (5 Suppl 6): 11.

  196. Todo S, Podesta L, Chap P et al. Orthotopic liver transplantation in dogs receiving FK-506. Transplant Proc 1987; 19 (5 Suppl 6): 64.

  197. Platz KP, Bechstein WO, Eckhoff DE et al. RS-61443 reverses acute allograft rejection in dogs. Surgery 1991; 110: 736.

  198. Watt DJ, Patridge TA, Sloper JC. Cyclosporin A as a means of preventing rejection of skeletal muscle allografts in mice. Transplantation 1981; 31: 266.




2020     |     www.medigraphic.com